SPY368.95+2.26 0.62%
DIA301.76+1.70 0.57%
IXIC12,452.81+75.63 0.61%

Eton Pharmaceuticals Q3 EPS $(0.31) Misses $(0.25) Estimate, Sales $161.00K

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 10.71 percent decrease over losses of $(0.28) per share

· 11/12/2020 16:27
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 10.71 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $161.00 thousand in sales this quarter.